Visualising Research Trends and Hotspots in Ferroptosis: a Decade of Insights into Iron-Dependent Cell Death and Clinical Diseases

Meng-Zhen Shi,Qian-Qian Wu,Xiao-Qian Liu,Zhan-Peng Guo,Yu-Ting Bai,Yan-Min Liu,Xiao-Ling Su,Ai-Ling Hu,Cun Guo,Yi-Zhu Peng,Jin-Chun Wu,Zhuo-Ya Jian,Hui Lu,Jie-Lin Lei
DOI: https://doi.org/10.1007/s11084-024-09662-5
2024-01-01
Abstract:To explore the research hotspots and frontier trends of ferroptosis and its association with clinical diseases both in China and internationally over the past decade. Utilizing the CNKI, PubMed, and Web of Science literature databases as data sources, we employed CiteSpace 6.2.R4 and VOSviewer software to visualize and analyze the authors, institutions, countries, and keywords related to ferroptosis and clinical diseases from 2013 to 2023. China Medical University has published the highest number of studies in the field of ferroptosis and clinical diseases in China. Furthermore, China leads globally in attention to this research area. In 2022, domestic and international scholars exhibited the closest collaboration in this field. The year 2020 saw the most extensive range of sub-studies on ferroptosis and clinical diseases both at home and abroad. The keywords "cancer" and "long non-coding RNAs (LncRNAs)" emerged as the most prominent research topics in recent years. Future research on ferroptosis-related diseases, including cancer, heart failure, type 2 diabetes, and Alzheimer's disease, should further investigate the regulatory mechanisms linking ferroptosis with mitochondria, the Golgi apparatus, and multi-site LncRNA interactions. This could provide valuable insights for subsequent studies on cancer and other diseases in the context of ferroptosis.
What problem does this paper attempt to address?